Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZCQ in Asymptomatic Pregnant Women with P. falciparum Parasitemia
NCT01103713Phase 3Terminated
- Sponsor
- Pfizer
- Start
- Mar 2011
- Primary completion
- Jun 2013
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 3 trial of azithromycin, chloroquine in Plasmodium falciparum malaria, sponsored by Pfizer. Started Mar 2011; status: terminated.
02
Drugs
azithromycinchloroquine
03
Conditions
Plasmodium falciparum malaria
Beyond the preview
Go deeper on NCT01103713.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01103713.